Furthermore, the partial reduction of infection in cells endogenously expressing both DPP4 and TMPRSS2 following treatment with a TMPRSS2 inhibitor, in contrast to the lack of inhibition in cells expressing only DPP4, confirms the dual entry path of MERS-CoV. The gene discussed is TMPRSS2; the disease is infection.